IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a focus in oncology and hematology, today announced that it has appointed James E. Shields, a seasoned pharmaceutical sales executive with a proven track record of establishing and leading commercial operations, to the position of Senior Vice President and Chief Commercial Officer. Mr. Shields’ appointment is an important component of the Company’s continued focus on maximizing the growth potential of its ZEVALIN® and FUSILEV® brands, and as it makes launch preparations for its other late-stage drugs in the near future.
